Authors: | Barth, M.; Xavier, A. C.; Armenian, S.; Audino, A. N.; Blazin, L.; Bloom, D.; Chung, J.; Davies, K.; Ding, H.; Ford, J. B.; Galardy, P. J.; Hanna, R.; Hayashi, R.; Lee-Miller, C.; Machnitz, A. J.; Maloney, K. W.; Marks, L.; Martin, P. L.; McCall, D.; Pacheco, M.; Reilly, A. F.; Roshal, M.; Song, S.; Weinstein, J.; Zarnegar-Lumley, S.; McMillian, N.; Schonfeld, R.; Sundar, H. |
Title: | Pediatric aggressive mature B-cell lymphomas, version 3.2022: NCCN Clinical Practice Guidelines in Oncology |
Abstract: | NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Aggressive Mature B-Cell Lymphomas include recommendations for the diagnosis and management of pediatric patients with primary mediastinal large B-cell lymphoma (PMBL) and sporadic variants of Burkitt lymphoma and diffuse large B-cell lymphoma. PMBL is now considered as a distinct entity arising from mature thymic B-cells accounting for 2% of mature B-cell lymphomas in children and adolescents. This discussion section includes the recommendations outlined in the NCCN Guidelines for the diagnosis and management of pediatric patients with PMBL. © 2022 Harborside Press. All rights reserved. |
Keywords: | adolescent; child; clinical feature; cancer recurrence; cancer diagnosis; diagnostic procedure; practice guideline; pathology; oncology; cancer therapy; biopsy; medical oncology; cancer epidemiology; lymphoma, large b-cell, diffuse; primary mediastinal large b-cell lymphoma; phase 2 clinical trial (topic); diffuse large b cell lymphoma; humans; human; article; pediatric patient |
Journal Title: | Journal of the National Comprehensive Cancer Network |
Volume: | 20 |
Issue: | 11 |
ISSN: | 1540-1405 |
Publisher: | Harborside Press |
Date Published: | 2022-11-01 |
Start Page: | 1267 |
End Page: | 1275 |
Language: | English |
DOI: | 10.6004/jnccn.2022.0057 |
PUBMED: | 36351334 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | Article -- Export Date: 1 December 2022 -- Source: Scopus |